Anil Kapur
Vermögen: 228 044 $ am 31.05.2026
Vermögen: 228 044 $ am 31.05.2026
Anil Kapur is currently an Independent Director at Verastem, Inc. since 2022, an independent Director at Nurix Therapeutics, Inc. since 2024, and Head-Legal at Sagar Ratna Restaurants Pvt Ltd. Former positions include Chief Commercial Officer & EVP-Corporate Strategy at Geron Corp.
from 2019 to 2024, Chief Commercial Officer at Actinium Pharmaceuticals, Inc. from 2018 to 2019, Vice President, Head-Early Assets & Biomarkers at Bristol Myers Squibb Co. from 2016 to 2018, VP, Global Head-Commercial & Portfolio Strategy at Baxalta, Inc. from 2015 to 2016, VP & Commercial Leader-Hematology Franchise at Johnson & Johnson from 2013 to 2015, and Legal Advisor at Paras Group.
Education includes undergraduate studies at Birla Institute of Technology & Science and Kurukshetra University, graduate studies at Louisiana Tech University and Kurukshetra University, and an MBA from The Fuqua School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VERASTEM, INC. 0.09% | 21.05.2026 | 52’666 ( 0.09% ) | 228 044 $ | 31.05.2026 |
| 15.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VERASTEM, INC. | Direktor/Vorstandsmitglied | 20.10.2022 |
| NURIX THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.10.2024 |
Sagar Ratna Restaurants Pvt Ltd.
Sagar Ratna Restaurants Pvt Ltd. RestaurantsConsumer Services Operates chain of restaurants | General Counsel | - |
| Unternehmen | Position | Ende |
|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | 31.08.2024 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29.11.2019 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.02.2018 |
| BAXALTA INC | Corporate Officer/Principal | 01.07.2016 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.11.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Birla Institute of Technology & Science
Birla Institute of Technology & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Louisiana Tech University
Louisiana Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kurukshetra University
Kurukshetra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paras Group
Paras Group Other Consumer ServicesConsumer Services Operates as a holding company with interest in personal care, healthcare, real estate, and information technology businesses | Consumer Services |
Verastem, Inc.
Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Sagar Ratna Restaurants Pvt Ltd.
Sagar Ratna Restaurants Pvt Ltd. RestaurantsConsumer Services Operates chain of restaurants | Consumer Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
The Fuqua School of Business
The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen